Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 183

1.

Participation in Cervical Screening by Self-collection, Pap, or a Choice of Either in Brazil.

Castle PE, Silva VRS, Consolaro MEL, Kienen N, Bittencourt L, Pelloso SM, Partridge EE, Pierz A, Dartibale CB, Uchimura NS, Scarinci IC.

Cancer Prev Res (Phila). 2019 Mar;12(3):159-170. doi: 10.1158/1940-6207.CAPR-18-0419. Epub 2019 Jan 16.

PMID:
30651294
2.

Unmet social support needs among older adults with cancer.

Williams GR, Pisu M, Rocque GB, Williams CP, Taylor RA, Kvale EA, Partridge EE, Bhatia S, Kenzik KM.

Cancer. 2019 Feb 1;125(3):473-481. doi: 10.1002/cncr.31809. Epub 2018 Dec 3.

PMID:
30508291
3.

Lay navigation across the cancer continuum for older cancer survivors: Equally beneficial for Black and White survivors?

Pisu M, Rocque GB, Jackson BE, Kenzik KM, Sharma P, Williams CP, Kvale EA, Taylor RA, Williams GR, Azuero A, Li Y, Acemgil A, Martin MY, Demark-Wahnefried W, Turkman Y, Fouad M, Rocconi RP, Sullivan M, Cantuaria G, Partridge EE, Meneses K.

J Geriatr Oncol. 2018 Oct 30. pii: S1879-4068(18)30239-X. doi: 10.1016/j.jgo.2018.10.013. [Epub ahead of print]

PMID:
30389494
4.

Cervical Cancer Screening among Underscreened and Unscreened Brazilian Women: Training Community Health Workers to be Agents of Change.

Kienen N, Bittencourt L, Pelloso SM, Consolaro ME, Castle PE, Partridge EE, Silva NR, Scarinci IC.

Prog Community Health Partnersh. 2018;12(1S):111-119. doi: 10.1353/cpr.2018.0026.

PMID:
29755054
5.

Lay Patient Navigators' Perspectives of Barriers, Facilitators and Training Needs in Initiating Advance Care Planning Conversations With Older Patients With Cancer.

Niranjan SJ, Huang CS, Dionne-Odom JN, Halilova KI, Pisu M, Drentea P, Kvale EA, Bevis KS, Butler TW, Partridge EE, Rocque GB.

J Palliat Care. 2018 Apr;33(2):70-78. doi: 10.1177/0825859718757131. Epub 2018 Feb 12.

PMID:
29432705
6.

Participation and interest in support services among family caregivers of older adults with cancer.

Dionne-Odom JN, Applebaum AJ, Ornstein KA, Azuero A, Warren PP, Taylor RA, Rocque GB, Kvale EA, Demark-Wahnefried W, Pisu M, Partridge EE, Martin MY, Bakitas MA.

Psychooncology. 2018 Mar;27(3):969-976. doi: 10.1002/pon.4603. Epub 2017 Dec 28.

7.

Radiation therapy utilization in Medicare beneficiaries with early-stage breast cancer.

Wallace AS, Keene KS, Williams CP, Jackson BE, Pisu M, Partridge EE, Rocque GB.

Cancer. 2018 Feb 1;124(3):475-481. doi: 10.1002/cncr.30989. Epub 2017 Oct 20.

8.

Where Are the Opportunities for Reducing Health Care Spending Within Alternative Payment Models?

Rocque GB, Williams CP, Kenzik KM, Jackson BE, Halilova KI, Sullivan MM, Rocconi RP, Azuero A, Kvale EA, Huh WK, Partridge EE, Pisu M.

J Oncol Pract. 2018 Jun;14(6):e375-e383. doi: 10.1200/JOP.2017.024935. Epub 2017 Oct 5.

PMID:
28981388
9.

Implementation and utilization of the molecular tumor board to guide precision medicine.

Harada S, Arend R, Dai Q, Levesque JA, Winokur TS, Guo R, Heslin MJ, Nabell L, Nabors LB, Limdi NA, Roth KA, Partridge EE, Siegal GP, Yang ES.

Oncotarget. 2017 Jun 14;8(34):57845-57854. doi: 10.18632/oncotarget.18471. eCollection 2017 Aug 22. Review.

10.

A Community Health Advisor Program to Reduce Cancer Screening Disparities in the Deep South and Appalachia: The American Cancer Society's CHA Collaborative.

Riehman KS, Fisher-Borne M, Martinez JM, Daven M, Thompson L, Fouad MN, Partridge EE.

Health Promot Pract. 2017 Sep;18(5):734-740. doi: 10.1177/1524839917696712. Epub 2017 Mar 7.

PMID:
28812927
11.

A higher degree of expression of DNA methyl transferase 1 in cervical cancer is associated with poor survival outcome.

Piyathilake CJ, Badiga S, Borak SG, Weragoda J, Bae S, Matthews R, Bell WC, Partridge EE.

Int J Womens Health. 2017 Jun 8;9:413-420. doi: 10.2147/IJWH.S133441. eCollection 2017.

12.

The self-care practices of family caregivers of persons with poor prognosis cancer: differences by varying levels of caregiver well-being and preparedness.

Dionne-Odom JN, Demark-Wahnefried W, Taylor RA, Rocque GB, Azuero A, Acemgil A, Martin MY, Astin M, Ejem D, Kvale E, Heaton K, Pisu M, Partridge EE, Bakitas MA.

Support Care Cancer. 2017 Aug;25(8):2437-2444. doi: 10.1007/s00520-017-3650-7. Epub 2017 Mar 1.

13.

Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States.

Yoo W, Kim S, Huh WK, Dilley S, Coughlin SS, Partridge EE, Chung Y, Dicks V, Lee JK, Bae S.

PLoS One. 2017 Feb 24;12(2):e0172548. doi: 10.1371/journal.pone.0172548. eCollection 2017.

14.

Feasibility of a Telehealth Educational Program on Self-Management of Pain and Fatigue in Adult Cancer Patients.

Rocque GB, Halilova KI, Varley AL, Williams CP, Taylor RA, Masom DG, Wright WJ, Partridge EE, Kvale EA.

J Pain Symptom Manage. 2017 Jun;53(6):1071-1078. doi: 10.1016/j.jpainsymman.2016.12.345. Epub 2017 Feb 6.

PMID:
28185891
15.

Resource Use and Medicare Costs During Lay Navigation for Geriatric Patients With Cancer.

Rocque GB, Pisu M, Jackson BE, Kvale EA, Demark-Wahnefried W, Martin MY, Meneses K, Li Y, Taylor RA, Acemgil A, Williams CP, Lisovicz N, Fouad M, Kenzik KM, Partridge EE; Patient Care Connect Group.

JAMA Oncol. 2017 Jun 1;3(6):817-825. doi: 10.1001/jamaoncol.2016.6307.

16.

Implementation and Impact of Patient Lay Navigator-Led Advance Care Planning Conversations.

Rocque GB, Dionne-Odom JN, Sylvia Huang CH, Niranjan SJ, Williams CP, Jackson BE, Halilova KI, Kenzik KM, Bevis KS, Wallace AS, Lisovicz N, Taylor RA, Pisu M, Partridge EE, Butler TW, Briggs LA, Kvale EA; Patient Care Connect Group.

J Pain Symptom Manage. 2017 Apr;53(4):682-692. doi: 10.1016/j.jpainsymman.2016.11.012. Epub 2017 Jan 3.

17.

Sociodemographic Patterns of Chronic Disease: How the Mid-South Region Compares to the Rest of the Country.

Oates GR, Jackson BE, Partridge EE, Singh KP, Fouad MN, Bae S.

Am J Prev Med. 2017 Jan;52(1S1):S31-S39. doi: 10.1016/j.amepre.2016.09.004.

18.

Advancing the Science of Health Disparities Through Research on the Social Determinants of Health.

Fouad MN, Oates GR, Scarinci IC, Demark-Wahnefried W, Hamby BW, Bateman LB, Estrada JJ, Payton M, Sims M, Miele L, Partridge EE.

Am J Prev Med. 2017 Jan;52(1 Suppl 1):S1-S4. doi: 10.1016/j.amepre.2016.09.032. No abstract available.

19.

Choosing Wisely: Opportunities for Improving Value in Cancer Care Delivery?

Rocque GB, Williams CP, Jackson BE, Wallace AS, Halilova KI, Kenzik KM, Partridge EE, Pisu M.

J Oncol Pract. 2017 Jan;13(1):e11-e21. doi: 10.1200/JOP.2016.015396. Epub 2016 Nov 15.

20.

Disparities in chronic medical conditions in the Mid-South.

Jackson BE, Oates GR, Singh KP, Shikany JM, Fouad MN, Partridge EE, Bae S.

Ethn Health. 2017 Apr;22(2):196-208. doi: 10.1080/13557858.2016.1232805. Epub 2016 Sep 29.

21.

Using Community Feedback to Improve Community Interventions: Results From the Deep South Network for Cancer Control Project.

Wynn TA, Wyatt SB, Hardy CM, Walker SS, Thomas TF, Williams AG, Partridge EE.

Fam Community Health. 2016 Oct-Dec;39(4):234-41. doi: 10.1097/FCH.0000000000000101.

22.

Treatment Summaries and Follow-Up Care Instructions for Cancer Survivors: Improving Survivor Self-Efficacy and Health Care Utilization.

Kenzik KM, Kvale EA, Rocque GB, Demark-Wahnefried W, Martin MY, Jackson BE, Meneses K, Partridge EE, Pisu M.

Oncologist. 2016 Jul;21(7):817-24. doi: 10.1634/theoncologist.2015-0517. Epub 2016 May 31.

23.

Accuracy of urinary human papillomavirus testing for the presence of cervical human papillomaviruses and higher grades of cervical intraepithelial neoplasia.

Piyathilake CJ, Badiga S, Chambers MM, Brill IK, Matthews R, Partridge EE.

Cancer. 2016 Sep 15;122(18):2836-44. doi: 10.1002/cncr.30123. Epub 2016 May 31.

24.

Patient Navigation As a Model to Increase Participation of African Americans in Cancer Clinical Trials.

Fouad MN, Acemgil A, Bae S, Forero A, Lisovicz N, Martin MY, Oates GR, Partridge EE, Vickers SM.

J Oncol Pract. 2016 Jun;12(6):556-63. doi: 10.1200/JOP.2015.008946. Epub 2016 May 17.

25.

The Patient Care Connect Program: Transforming Health Care Through Lay Navigation.

Rocque GB, Partridge EE, Pisu M, Martin MY, Demark-Wahnefried W, Acemgil A, Kenzik K, Kvale EA, Meneses K, Li X, Li Y, Halilova KI, Jackson BE, Chambless C, Lisovicz N, Fouad M, Taylor RA.

J Oncol Pract. 2016 Jun;12(6):e633-42. doi: 10.1200/JOP.2015.008896. Epub 2016 May 10.

26.

Guiding Lay Navigation in Geriatric Patients With Cancer Using a Distress Assessment Tool.

Rocque GB, Taylor RA, Acemgil A, Li X, Pisu M, Kenzik K, Jackson BE, Halilova KI, Demark-Wahnefried W, Meneses K, Li Y, Martin MY, Chambless C, Lisovicz N, Fouad M, Partridge EE, Kvale EA; Patient Care Connect Group.

J Natl Compr Canc Netw. 2016 Apr;14(4):407-14.

27.

Molecular Mechanism Linking BRCA1 Dysfunction to High Grade Serous Epithelial Ovarian Cancers with Peritoneal Permeability and Ascites.

Desai A, Xu J, Aysola K, Akinbobuyi O, White M, Reddy VE, Okoli J, Clark C, Partridge EE, Childs E, Beech DJ, Rice MV, Reddy E, Rao VN.

J Gynecol Res. 2015;1(1). pii: 103. Epub 2015 Apr 24.

28.

Shifting Community-Based Participatory Infrastructure from Education/Outreach to Research: Challenges and Solutions.

Partridge EE, Hardy CM, Baskin ML, Fouad M, Willis L, James G, Wynn T.

Prog Community Health Partnersh. 2015;9 Suppl:33-9. doi: 10.1353/cpr.2015.0019.

29.

A study of the relationship between food group recommendations and perceived stress: findings from black women in the Deep South.

Carson TL, Desmond R, Hardy S, Townsend S, Ard JD, Meneses K, Partridge EE, Baskin ML.

J Obes. 2015;2015:203164. doi: 10.1155/2015/203164. Epub 2015 Mar 4.

30.

A Novel Pathway that Links Caveolin-1 Down-Regulation to BRCA1 Dysfunction in Serous Epithelial Ovarian Cancer Cells.

Xu J, Agyemang S, Qin Y, Aysola K, Giles M, Oprea G, O'Regan RM, Partridge EE, Harris-Hooker S, Rice VM, Reddy ES, Rao VN.

Enliven Chall Cancer Detect Ther. 2014;1(1). pii: 004.

31.

Epithelial ovarian cancer: An overview.

Desai A, Xu J, Aysola K, Qin Y, Okoli C, Hariprasad R, Chinemerem U, Gates C, Reddy A, Danner O, Franklin G, Ngozi A, Cantuaria G, Singh K, Grizzle W, Landen C, Partridge EE, Rice VM, Reddy ES, Rao VN.

World J Transl Med. 2014 Apr 12;3(1):1-8.

32.

Assessing the risk of ovarian malignancy in asymptomatic women with abnormal findings: "tilting at windmills".

Partridge EE, Spencer EB.

Gynecol Oncol. 2014 Oct;135(1):1-2. doi: 10.1016/j.ygyno.2014.08.038. No abstract available.

PMID:
25315419
33.

Functional variants in CYP1A1 and GSTM1 are associated with clearance of cervical HPV infection.

Sudenga SL, Shrestha S, Macaluso M, Partridge EE, Johanning GL, Piyathilake CJ.

Gynecol Oncol. 2014 Dec;135(3):560-4. doi: 10.1016/j.ygyno.2014.09.015. Epub 2014 Oct 1.

34.

Disparities in cervical cancer mortality rates as determined by the longitudinal hyperbolastic mixed-effects type II model.

Tabatabai MA, Kengwoung-Keumo JJ, Eby WM, Bae S, Guemmegne JT, Manne U, Fouad M, Partridge EE, Singh KP.

PLoS One. 2014 Sep 16;9(9):e107242. doi: 10.1371/journal.pone.0107242. eCollection 2014.

35.

Folate and vitamin B12 may play a critical role in lowering the HPV 16 methylation-associated risk of developing higher grades of CIN.

Piyathilake CJ, Macaluso M, Chambers MM, Badiga S, Siddiqui NR, Bell WC, Edberg JC, Partridge EE, Alvarez RD, Johanning GL.

Cancer Prev Res (Phila). 2014 Nov;7(11):1128-37. doi: 10.1158/1940-6207.CAPR-14-0143. Epub 2014 Aug 21.

36.

Yes, minority and underserved populations will participate in biospecimen collection.

Partridge EE.

Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):895-7. doi: 10.1158/1055-9965.EPI-14-0018. No abstract available.

37.

Oxidatively modified proteins in the serous subtype of ovarian carcinoma.

Mehrabi S, Partridge EE, Seffens W, Yao X, Aikhionbare FO.

Biomed Res Int. 2014;2014:585083. doi: 10.1155/2014/585083. Epub 2014 Mar 27.

38.

Adherence and retention in clinical trials: a community-based approach.

Fouad MN, Johnson RE, Nagy MC, Person SD, Partridge EE.

Cancer. 2014 Apr 1;120 Suppl 7:1106-12. doi: 10.1002/cncr.28572.

39.

Cervical cancer screening.

Partridge EE, Abu-Rustum N, Giuliano A, Massad S, McClure J, Dwyer M, Hughes M; National comprehensive cancer network.

J Natl Compr Canc Netw. 2014 Mar 1;12(3):333-41; quiz 341.

PMID:
24616539
40.

Considerations for bio-specimen collection among black women residing in the rural Deep South participating in a cancer prevention study.

Carson TL, Hardy CM, Greene E, Carter PL, James G, Partridge EE, Baskin ML.

J Community Genet. 2014 Jul;5(3):257-63. doi: 10.1007/s12687-013-0178-5. Epub 2013 Dec 15. No abstract available.

41.

Acceptability and usability of self-collected sampling for HPV testing among African-American women living in the Mississippi Delta.

Scarinci IC, Litton AG, Garc├ęs-Palacio IC, Partridge EE, Castle PE.

Womens Health Issues. 2013 Mar-Apr;23(2):e123-30. doi: 10.1016/j.whi.2012.12.003. Epub 2013 Feb 12.

42.

Cervical cancer screening preferences among African American women in the Mississippi Delta.

Litton AG, Castle PE, Partridge EE, Scarinci IC.

J Health Care Poor Underserved. 2013 Feb;24(1):46-55. doi: 10.1353/hpu.2013.0017.

PMID:
23377716
43.

A lower degree of PBMC L1 methylation is associated with excess body weight and higher HOMA-IR in the presence of lower concentrations of plasma folate.

Piyathilake CJ, Badiga S, Alvarez RD, Partridge EE, Johanning GL.

PLoS One. 2013;8(1):e54544. doi: 10.1371/journal.pone.0054544. Epub 2013 Jan 24.

44.

Human papillomavirus genotypes detected in clinician-collected and self-collected specimens from women living in the Mississippi Delta.

Castle PE, Gage JC, Partridge EE, Rausa A, Gravitt PE, Scarinci IC.

BMC Infect Dis. 2013 Jan 7;13:5. doi: 10.1186/1471-2334-13-5.

45.

Assessing the risk of ovarian malignancy in asymptomatic women with abnormal CA 125 and transvaginal ultrasound scans in the prostate, lung, colorectal, and ovarian screening trial.

Partridge EE, Greenlee RT, Riley TL, Commins J, Ragard L, Xu JL, Buys SS, Prorok PC, Fouad MN.

Obstet Gynecol. 2013 Jan;121(1):25-31. doi: http://10.1097/AOG.0b013e3182755e14.

46.

Disparities in use of gynecologic oncologists for women with ovarian cancer in the United States.

Austin S, Martin MY, Kim Y, Funkhouser EM, Partridge EE, Pisu M.

Health Serv Res. 2013 Jun;48(3):1135-53. doi: 10.1111/1475-6773.12012. Epub 2012 Dec 3.

47.

BRCA1 proteins regulate growth of ovarian cancer cells by tethering Ubc9.

Qin Y, Xu J, Aysola K, Oprea G, Reddy A, Matthews R, Okoli J, Cantor A, Grizzle WE, Partridge EE, Reddy ES, Landen C, Rao VN.

Am J Cancer Res. 2012;2(5):540-8. Epub 2012 Aug 20.

48.

A dietary pattern associated with LINE-1 methylation alters the risk of developing cervical intraepithelial neoplasia.

Piyathilake CJ, Badiga S, Kabagambe EK, Azuero A, Alvarez RD, Johanning GL, Partridge EE.

Cancer Prev Res (Phila). 2012 Mar;5(3):385-92. doi: 10.1158/1940-6207.CAPR-11-0387. Epub 2012 Jan 18.

49.

Comparative performance of human papillomavirus DNA testing using novel sample collection methods.

Gage JC, Partridge EE, Rausa A, Gravitt PE, Wacholder S, Schiffman M, Scarinci I, Castle PE.

J Clin Microbiol. 2011 Dec;49(12):4185-9. doi: 10.1128/JCM.01254-11. Epub 2011 Oct 12.

50.

Usefulness of serum mass spectrometry to identify women diagnosed with higher grades of cervical intraepithelial neoplasia may differ by race.

Matthews R, Azuero A, Asmellash S, Brewster E, Partridge EE, Piyathilake CJ.

Int J Womens Health. 2011;3:185-92. doi: 10.2147/IJWH.S20685. Epub 2011 Jul 12.

Supplemental Content

Loading ...
Support Center